15 August 2024
15 August 2024
Kezar plans to focus all efforts on zetomipzomib, which is being evaluated in two Phase II trials for lupus and autoimmune hepatitis.
Africa CDC鈥檚 Director-General Dr Jean Kaseya stated the number of rising mpox cases in the continent has been 鈥渓argely ignored鈥�.
Replimune has announced the first patient in the Phase III melanoma trial with its lead immunotherapy RP1 or vusolimogene oderparepvec has been dosed and randomised.
As part of pipeline reprioritisation, Acelyrin has dropped izokibep and will instead start Phase III trials for lonigutamab in Q1 2025.
The approval of Leqembi in the UAE is based on results from the extensive global Phase III Clarity study.
The conditional approval by the NMPA was influenced by the positive outcomes of the DESTINY-Gastric06 Phase II trial.
The facility will focus on RNA and DNA-based therapies and discover new drug targets for diabetes, obesity and cardiovascular issues.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
